AVAC tracks global PrEP use by conducting quarterly surveys of ongoing oral PrEP demonstration and implementation projects, and collecting data from manufacturers and government agencies. This graphic shows data on PrEP initiations around the globe. For more trends in oral PrEP uptake, visit PrEPWatch.
PrEP Initiations by Country Worldwide
Avac Event
Illinois PrEP Summit 2024: Disrupting Disparities and Advancing Access
The conference focuses on advancing biomedical HIV prevention to help achieve Getting to Zero by 2030. Key summit goals include improving access, addressing disparities, fostering research and promoting community engagement. Join us for in-person sessions covering strategies, policies and implementation research.
This conference is curated by AFC, MATEC, PrEP4Teens and Project VIDA.
Registration closes, June 7, 2024.
Avac Event
HIV, Viral Hepatitis and Sexually Transmitted Infections: Progress and gaps
13:00 – 14:30 CEST PM
Please join this webinar being held in the run up to the 77th World Health Assembly.
The World Health Organization (WHO) will launch a publication, which describes progress and gaps identified during the first two years of implementing the global health sector strategies on HIV, viral hepatitis and sexually transmitted infections (STIs) for 2022-2030.
Moderators will ask key leaders in the responses to HIV, viral hepatitis and STIs how we can increase visibility, political will and community activism to accelerate action.
Panelists include:
- Jérôme Salomon, WHO, Switzerland
- Jessica Hicks, World Hepatitis Alliance, United Kingdom
- Maureen Luba, AVAC, Malawi
- Meg Doherty, WHO, Switzerland
- Patty Garcia, Cayetano Heredia University, Peru
- Philippe Duneton, Unitaid, Switzerland
- Sabin Nsanzimana, Ministry of Health, Rwanda (TBC)
The conversation will be moderated by Charles Gore from the Medicines Patent Pool (MPP) and Birgit Poniatowski from IAS – the International AIDS Society.
The webinar is organized by IAS – the International AIDS Society – and its partners, WHO, Medicines Patent Pool and Unitaid.
Cabotegravir Long-Acting Injectable for Prevention
Frequently Asked Questions
Afrocab has developed a FAQ (below) that covers the topics of PrEP and explains how CAB-LA works, is taken, and its side effects.
Biomedical HIV Prevention Summit and PrEP in Black America Summit
AVAC Highlights
1,000+ community advocates, researchers, policy experts, federal public health leadership, medical and service providers attended the NMAC annual Biomedical HIV Prevention Summit in Seattle. The discussion and debate on PrEP access, especially for racial and ethnic minorities and key populations, PrEP research, care, policy and community-based programs are ones to follow.
The Years Ahead in Biomedical HIV Prevention Research
This graphic shows the updated status of large-scale prevention trials through the end of 2024.
Allocation of Non-Commercial CAB for PrEP Supply in Low- and Middle-Income Countries, 2023-2025
Biomedical HIV Prevention Summit and PrEP in Black America Summit
AVAC Highlights
Last week, 1,000+ community advocates, researchers, policy experts, federal public health leadership, medical and service providers from around the US and Puerto Rico attended the NMAC annual Biomedical HIV Prevention Summit in Seattle, Washington. The discussion and debate on PrEP access, especially for racial and ethnic minorities and key populations, PrEP research, care, policy and community-based programs are ones to follow. AVAC’s John Meade (Senior Program Manager, Policy), Jessica Salzwedel (Senior Program Manager: Research Engagement) and Kenyon Farrow (Communications Director) presented in workshops and satellite sessions at the Summit and at the PrEP in Black America preconference
The Summit included sessions that updated community advocates on the latest in biomedical research for new diagnostics, PrEP, PEP, STIs and vaccines. Meade co-presented a Clinical Trials 101 for community advocates to learn more about the research process. Farrow presented an epidemiological overview on HIV and Disparities in the United States for NMAC’s Gay Men of Color Fellows.
All three AVAC staff contributed to the PrEP in Black America: The State of HIV Prevention Research in the Black Community pre-conference, organized by PrEP in Black America (PIBA). PIBA began in 2022 as a community-led effort to increase Black community mobilization and engagement in PrEP research, policy and access programs. Farrow and Meade are PIBA cofounders, and Meade facilitated the day’s agenda, with more than 200 attendees focused on identifying the research gaps that need to be addressed to increase knowledge, access and use of PrEP. Data shows that while Black people in the U.S. make up 42% of all new HIV diagnoses in 2021, they were only 14% of all PrEP users. By comparison, white Americans are 65% of all PrEP users, but only 26% of all people diagnosed with HIV in the same year.
Salzwedel co-led the closing consensus session at PIBA, a discussion where attendees named research priorities to be later released as part of a National Black-Centered Biomedical HIV Prevention research agenda. One of the most important priorities named, however, goes beyond singling out the right research questions. Attendees showed strong consensus that the research process itself needs to change. Attendees expressed a need and desire for more investment and commitment to community-led research, that can reflect non-traditional ways of gathering data and designing trials and ending the extractive approach that characterizes conventional researcher/community relationships.
To stay up to date with PrEP in Black America, follow them on Instagram and Facebook.
Join AVAC, The Choice Agenda, PrEP4All and HIVMA on Friday, April 26 for a special follow-up webinar, We Can’t End HIV in the United States Without Equitable PrEP Access: Strategies for success. Register here.
Avac Event
PrEP and the Role of HIV Self-Testing
HIV self-testing (HIVST) is a safe, accurate, and effective alternative to provider-administered testing that many users prefer for its convenience and confidentiality. At IAS 2023, WHO issued a new recommendation to offer HIVST for PrEP initiation and continuation as an innovative way to increase PrEP access and coverage and further simplify PrEP delivery. However, many implementers still have questions on how to effectively roll out and scale up this important self-care intervention.
On May 23, AVAC and WHO hosted a webinar to learn more about WHO guidance on use of HIVST and to hear directly from a panel of experts on their experiencing rolling out HIVST for PrEP, guidance on procurement and costing, and more.
Recording / Slides
For Us by Us: PrEP in Black America – A Master Plan for HIV Prevention in Black America
In the spirit of seeking change to ameliorate the devastating impact of HIV in Black communities through biomedical HIV prevention, Black leaders convened the “PrEP in Black America (PIBA) Summit” virtually and in person on September 13, 2022, in Atlanta, Georgia. Attendees have included Black activists, researchers, scientists, providers, and policymakers from across the country representing more than 50 organizations. Following the event, PIBA generated a report summarizing the event and key recommendations entitled, “For Us by Us: PrEP in Black America – A Master Plan for HIV Prevention in Black America.”